FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2100961085> ?p ?o ?g. }

• W2100961085 endingPage "2098" @default.
• W2100961085 startingPage "2091" @default.
• W2100961085 abstract "Induction chemotherapy with cisplatin plus fluorouracil followed by radiotherapy is the standard alternative to total laryngectomy for patients with locally advanced laryngeal cancer. The value of adding chemotherapy to radiotherapy and the optimal timing of chemotherapy are unknown.We randomly assigned patients with locally advanced cancer of the larynx to one of three treatments: induction cisplatin plus fluorouracil followed by radiotherapy, radiotherapy with concurrent administration of cisplatin, or radiotherapy alone. The primary end point was preservation of the larynx.A total of 547 patients were randomly assigned to one of the three study groups. The median follow-up period was 3.8 years. At two years, the proportion of patients who had an intact larynx after radiotherapy with concurrent cisplatin (88 percent) differed significantly from the proportions in the groups given induction chemotherapy followed by radiotherapy (75 percent, P=0.005) or radiotherapy alone (70 percent, P<0.001). The rate of locoregional control was also significantly better with radiotherapy and concurrent cisplatin (78 percent, vs. 61 percent with induction cisplatin plus fluorouracil followed by radiotherapy and 56 percent with radiotherapy alone). Both of the chemotherapy-based regimens suppressed distant metastases and resulted in better disease-free survival than radiotherapy alone. However, overall survival rates were similar in all three groups. The rate of high-grade toxic effects was greater with the chemotherapy-based regimens (81 percent with induction cisplatin plus fluorouracil followed by radiotherapy and 82 percent with radiotherapy with concurrent cisplatin, vs. 61 percent with radiotherapy alone). The mucosal toxicity of concurrent radiotherapy and cisplatin was nearly twice as frequent as the mucosal toxicity of the other two treatments during radiotherapy.In patients with laryngeal cancer, radiotherapy with concurrent administration of cisplatin is superior to induction chemotherapy followed by radiotherapy or radiotherapy alone for laryngeal preservation and locoregional control." @default.
• W2100961085 created "2016-06-24" @default.
• W2100961085 creator A5005803971 @default.
• W2100961085 creator A5012462054 @default.
• W2100961085 creator A5014446368 @default.
• W2100961085 creator A5015488796 @default.
• W2100961085 creator A5021506059 @default.
• W2100961085 creator A5034392417 @default.
• W2100961085 creator A5036014755 @default.
• W2100961085 creator A5037043658 @default.
• W2100961085 creator A5038655872 @default.
• W2100961085 creator A5046702807 @default.
• W2100961085 creator A5047627835 @default.
• W2100961085 creator A5056841878 @default.
• W2100961085 creator A5057756396 @default.
• W2100961085 creator A5058702476 @default.
• W2100961085 creator A5073466449 @default.
• W2100961085 date "2003-11-27" @default.
• W2100961085 modified "2023-10-13" @default.
• W2100961085 title "Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer" @default.
• W2100961085 cites W1969965083 @default.
• W2100961085 cites W2073140442 @default.
• W2100961085 cites W2083593358 @default.
• W2100961085 cites W2109694492 @default.
• W2100961085 cites W2147977201 @default.
• W2100961085 cites W2562414697 @default.
• W2100961085 cites W3041047318 @default.
• W2100961085 cites W4240814623 @default.
• W2100961085 cites W4246724958 @default.
• W2100961085 doi "https://doi.org/10.1056/nejmoa031317" @default.
• W2100961085 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14645636" @default.
• W2100961085 hasPublicationYear "2003" @default.
• W2100961085 type Work @default.
• W2100961085 sameAs 2100961085 @default.
• W2100961085 citedByCount "2658" @default.
• W2100961085 countsByYear W21009610852012 @default.
• W2100961085 countsByYear W21009610852013 @default.
• W2100961085 countsByYear W21009610852014 @default.
• W2100961085 countsByYear W21009610852015 @default.
• W2100961085 countsByYear W21009610852016 @default.
• W2100961085 countsByYear W21009610852017 @default.
• W2100961085 countsByYear W21009610852018 @default.
• W2100961085 countsByYear W21009610852019 @default.
• W2100961085 countsByYear W21009610852020 @default.
• W2100961085 countsByYear W21009610852021 @default.
• W2100961085 countsByYear W21009610852022 @default.
• W2100961085 countsByYear W21009610852023 @default.
• W2100961085 crossrefType "journal-article" @default.
• W2100961085 hasAuthorship W2100961085A5005803971 @default.
• W2100961085 hasAuthorship W2100961085A5012462054 @default.
• W2100961085 hasAuthorship W2100961085A5014446368 @default.
• W2100961085 hasAuthorship W2100961085A5015488796 @default.
• W2100961085 hasAuthorship W2100961085A5021506059 @default.
• W2100961085 hasAuthorship W2100961085A5034392417 @default.
• W2100961085 hasAuthorship W2100961085A5036014755 @default.
• W2100961085 hasAuthorship W2100961085A5037043658 @default.
• W2100961085 hasAuthorship W2100961085A5038655872 @default.
• W2100961085 hasAuthorship W2100961085A5046702807 @default.
• W2100961085 hasAuthorship W2100961085A5047627835 @default.
• W2100961085 hasAuthorship W2100961085A5056841878 @default.
• W2100961085 hasAuthorship W2100961085A5057756396 @default.
• W2100961085 hasAuthorship W2100961085A5058702476 @default.
• W2100961085 hasAuthorship W2100961085A5073466449 @default.
• W2100961085 hasBestOaLocation W21009610851 @default.
• W2100961085 hasConcept C121608353 @default.
• W2100961085 hasConcept C126322002 @default.
• W2100961085 hasConcept C126894567 @default.
• W2100961085 hasConcept C141071460 @default.
• W2100961085 hasConcept C143998085 @default.
• W2100961085 hasConcept C2776611710 @default.
• W2100961085 hasConcept C2776694085 @default.
• W2100961085 hasConcept C2778239845 @default.
• W2100961085 hasConcept C2780456651 @default.
• W2100961085 hasConcept C2780474809 @default.
• W2100961085 hasConcept C2781157581 @default.
• W2100961085 hasConcept C509974204 @default.
• W2100961085 hasConcept C71924100 @default.
• W2100961085 hasConceptScore W2100961085C121608353 @default.
• W2100961085 hasConceptScore W2100961085C126322002 @default.
• W2100961085 hasConceptScore W2100961085C126894567 @default.
• W2100961085 hasConceptScore W2100961085C141071460 @default.
• W2100961085 hasConceptScore W2100961085C143998085 @default.
• W2100961085 hasConceptScore W2100961085C2776611710 @default.
• W2100961085 hasConceptScore W2100961085C2776694085 @default.
• W2100961085 hasConceptScore W2100961085C2778239845 @default.
• W2100961085 hasConceptScore W2100961085C2780456651 @default.
• W2100961085 hasConceptScore W2100961085C2780474809 @default.
• W2100961085 hasConceptScore W2100961085C2781157581 @default.
• W2100961085 hasConceptScore W2100961085C509974204 @default.
• W2100961085 hasConceptScore W2100961085C71924100 @default.
• W2100961085 hasIssue "22" @default.
• W2100961085 hasLocation W21009610851 @default.
• W2100961085 hasLocation W21009610852 @default.
• W2100961085 hasOpenAccess W2100961085 @default.
• W2100961085 hasPrimaryLocation W21009610851 @default.
• W2100961085 hasRelatedWork W1990604199 @default.
• W2100961085 hasRelatedWork W2023463542 @default.
• W2100961085 hasRelatedWork W2139450301 @default.

• next